Fundraising Fox
/Companies
Sign in

Avita Medical

NASDAQ: RCEL

Melbourne, US · 1 known investors

Find your way into Avita Medical

Sign up to see every warm intro you have to Avita Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Avita Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

RECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.

BiotechHealthtechMedical Devices

Founders & leadership

FW
Fiona Wood
DADale A Sander
Dale A SanderChief Financial Officer2017–2019Dale A Sander served as Chief Financial Officer at six life science and business service companies through private and public phases, overseeing financial strategy, corporate development, M&A, and operations across multiple continents. He has led over 25 public and private equity and debt offerings, including three U.S. and European IPOs, and managed company growth ranging from startups to organizations with 60,000 employees.
CVCary Vance
Cary VancePresident & CEOCary Vance is Executive Chairman and Interim Chief Executive Officer of Avita Medical, an FDA-approved autologous skin cell suspension device company. He brings extensive leadership experience in medical technology, business development, and operational optimization, including Lean/Six Sigma certification.

Investors · 1

Reported raises · per SEC filings

Form D private placements

$29.7M disclosed across 2 rounds · 2018–2019

▶$15.4MraisedNov 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy RooneyExecutive Officer
Offering amount
$15.4M
Amount sold
$15.4M
Finders' fees
$461.2K
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.4MraisedFeb 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dale A SanderExecutive Officer
Offering amount
$14.4M
Amount sold
$14.4M
Finders' fees
$1.3M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

AiVita BiomedicalAIVITA Biomedical is a biotechnology company developing personalized vaccines using an autologous cell therapy platform, including a pan-antigenic cancer vaccine that targets all neoantigens and a multi-pathogen vaccine kit for infectious disease prevention. Its work draws on expertise in stem cell growth and high-purity cell differentiation.

Companies working in the same space as Avita Medical.

Frequently asked questions

What does Avita Medical do?
RECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.
Who founded Avita Medical?
Avita Medical was founded by Fiona Wood.
Who are Avita Medical's investors?
Avita Medical's investors include OrbiMed.
How much funding has Avita Medical raised?
Avita Medical has disclosed $29.7M raised across 2 rounds.
Where is Avita Medical headquartered?
Avita Medical is headquartered in Melbourne, US.